title: Epigenetic control of metastasis-associated protein 1 gene expression by hepatitis B virus X protein during hepatocarcinogenesis.
abstract: Expression of metastasis-associated protein 1 (MTA1) gene correlates with the degree of invasion and metastasis in hepatocellular carcinoma (HCC). Expression of MTA1 is induced by hepatitis B virus X protein (HBx); however, little is known about the transcriptional regulation of MTA1 gene expression. Here, we report that the 5'-flanking region of the human MTA1 promoter contains two CpG islands. Transient expression of HBx in Chang liver cells increased the methylation of the CpG island1 from 18 to 49% when measured by bisulfite-modified direct sequencing. Chromatin immunoprecipitation showed that HBx recruited DNA methyltransferase 3a (DNMT3a) and DNMT3b to the CpG island1. In silico analysis of CpG island1 predicted the existence of putative p53-binding sequences. p53 was pulled down by a DNA probe encoding the p53-binding sequences but not by the methylated DNA probe. The mouse MTA1 promoter also contains a CpG island encoding a p53-binding sequence of which p53 binding was decreased in the presence of HBx, and the expression of MTA1 and DNMT3 was increased in the liver of HBx-transgenic mice. Comparison of MTA1 and DNMT3a expression in the human normal liver and HCC specimens produced a significant correlation coefficient >0.5 (r=0.5686, P=0.0001) for DNMT3a, and a marginally significant coefficient (r=0.3162, P=0.0103) for DNMT3b. These data show that HBx induces methylation of CpG island in the MTA1 promoter, which interferes with DNA binding of p53 in the specific DNA region. This result may explain the molecular mechanism responsible for the induction of MTA1 gene expression by HBx.
authors.affiliation: 1] College of Pharmacy, Seoul National University, Seoul, Republic of Korea [2] Bio-MAX Institute, Seoul National University, Seoul, Republic of Korea [3] Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
authors.forename: M-H
authors.initials: MH
authors.lastname: Lee
authors.forename: H
authors.initials: H
authors.lastname: Na
authors.forename: T-Y
authors.initials: TY
authors.lastname: Na
authors.forename: Y-K
authors.initials: YK
authors.lastname: Shin
authors.forename: J-K
authors.initials: JK
authors.lastname: Seong
authors.forename: M-O
authors.initials: MO
authors.lastname: Lee
references.citation: Oncogene. 2010 Feb 25;29(8):1179-89
references.pmid: 20010875
references.citation: Oncogene. 2007 Apr 2;26(15):2166-76
references.pmid: 17401425
references.citation: Hepatology. 2009 Aug;50(2):490-9
references.pmid: 19472311
references.citation: J Viral Hepat. 2010 Feb 1;17(2):98-107
references.pmid: 19732323
references.citation: Hepatology. 2002 Sep;36(3):692-701
references.pmid: 12198663
references.citation: Cell. 2004 Dec 17;119(6):861-72
references.pmid: 15607981
references.citation: Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14707-12
references.pmid: 9405677
references.citation: J Gen Virol. 2010 Feb;91(Pt 2):493-500
references.pmid: 19828754
references.citation: J Med Virol. 2005 Nov;77(3):374-81
references.pmid: 16173017
references.citation: Int J Cancer. 2007 Mar 15;120(6):1208-14
references.pmid: 17187364
references.citation: Int J Cancer. 2003 Jul 1;105(4):527-32
references.pmid: 12712445
references.citation: Oncogene. 2005 Oct 6;24(44):6617-25
references.pmid: 16007161
references.citation: Nucleic Acids Res. 2007;35(4):1245-56
references.pmid: 17267411
references.citation: Oncogene. 2000 Jan 20;19(3):468-71
references.pmid: 10656696
references.citation: J Huazhong Univ Sci Technolog Med Sci. 2011 Feb;31(1):1-9
references.pmid: 21336715
references.citation: Hum Pathol. 2004 Apr;35(4):424-9
references.pmid: 15116322
references.citation: Trends Biochem Sci. 2006 Feb;31(2):89-97
references.pmid: 16403636
references.citation: Prostate. 2011 Feb 15;71(3):268-80
references.pmid: 20717904
references.citation: World J Gastroenterol. 2008 Mar 21;14(11):1741-8
references.pmid: 18350605
references.citation: J Biol Chem. 2010 Mar 5;285(10):6980-6
references.pmid: 20022949
references.citation: Biol Cell. 2007 Oct;99(10):573-81
references.pmid: 17868030
references.citation: Hepatology. 2008 Mar;47(3):929-36
references.pmid: 18306220
references.citation: Cancer Lett. 2006 Feb 28;233(2):271-8
references.pmid: 15885882
references.citation: J Clin Virol. 2005 Dec;34 Suppl 1:S75-8
references.pmid: 16461228
references.citation: Oncol Rep. 2005 Oct;14(4):975-9
references.pmid: 16142360
references.citation: Hepatology. 2010 Jan;51(1):142-53
references.pmid: 20034025
references.citation: J Biol Chem. 1998 Jun 26;273(26):16517-20
references.pmid: 9632720
references.citation: Gastroenterology. 2007 Apr;132(4):1476-94
references.pmid: 17408664
references.citation: CA Cancer J Clin. 2010 Nov-Dec;60(6):376-92
references.pmid: 20959400
references.citation: Oncogene. 2008 May 29;27(24):3405-13
references.pmid: 18264140
references.citation: Hepatology. 2009 Apr;49(4):1122-31
references.pmid: 19105208
references.citation: Anticancer Res. 2007 Jul-Aug;27(4B):2269-74
references.pmid: 17695513
references.citation: J Biol Chem. 2003 Oct 3;278(40):39076-84
references.pmid: 12855680
references.citation: Oncogene. 2009 May 14;28(19):2046-50
references.pmid: 19363521
references.citation: Mutat Res. 2011 May-Jun;727(3):55-61
references.pmid: 21514401
references.citation: Mol Cell Biol. 2005 Feb;25(4):1228-37
references.pmid: 15684377
references.citation: Nature. 2009 Oct 15;461(7266):1007-12
references.pmid: 19829383
references.citation: Oncogene. 2012 Dec 6;31(49):5099-107
references.pmid: 22286760
references.citation: Hepatology. 2001 May;33(5):1270-81
references.pmid: 11343256
references.citation: FASEB J. 1999 Sep;13(12):1518-22
references.pmid: 10463942
references.citation: Hepatology. 2007 May;45(5):1129-38
references.pmid: 17464989
references.citation: J Hepatol. 2010 Apr;52(4):594-604
references.pmid: 20185200
references.citation: J Lab Clin Med. 2006 Feb;147(2):58-66
references.pmid: 16459163